Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
BSE detected in US dairy cow
USDA confirms fourth US case

Officials of the United States Department of Agriculture (USDA) have confirmed that a single dairy cow in California has tested positive for bovine spongiform encephalopathy (BSE). The USDA also confirmed that the animal died on a farm in central California before it could be presented for slaughter and therefore never reached either the food or feed chains. Consequently, there has been no risk to human health.

It is understood that the cow was first noticed to be nonambulatory (colloquially, a 'downer') at the farm of origin, and the carcass is currently being held at a rendering facility under the authority of the State of California prior to its destruction. Western Blot tests and immunohistochemistry have established that the cow had atypical BSE, an exceptionally rare variant of the disease not usually associated with the consumption of infected feed but instead acquired spontaneously.

Commenting, USDA Chief Veterinary Officer John Clifford has emphasized that "This detection in no way affects the United States' BSE status as determined by the OIE [World Animal Health]. The United States has in place all of the elements of a system that OIE has determined ensures that beef and beef products are safe for human consumption: a mammalian feed ban, removal of specified risk materials, and vigorous surveillance. Consequently, this detection should not affect U.S. Trade." 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'